WebbShape has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Shape is backed by … Webb16 juli 2024 · Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The company’s RNA …
Seattle-based Shape Therapeutics raises $112M to develop
WebbOKLAHOMA CITY, OK, April 13, 2024 – Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development and small batch CGMP production of therapeutic antibodies, announced the closing of their Series A financing round. Webb11 apr. 2024 · Chief Scientific Officer at Shape Therapeutics, Inc. 3w Edited Interested in exploring a universe of possibilities when AI and RNA collide? The ShapeTX Research team in Seattle is hiring! Take a ... siccin horror movie
Shape Therapeutics enters into a strategic research
Webbför 10 timmar sedan · In the last 3 months, 18 analysts have offered 12-month price targets for Sarepta Therapeutics. The company has an average price target of $175.28 with a high of $226.00 and a low of $137.00 ... WebbBristol Myers details landmark Abecma multiple myeloma data that ASH turned down. Feb 10, 2024 11:34am. WebbShapeTX is developing Gene Therapies using proprietary RNA technologies. The ShapeTX technology platform includes RNAskip™, a proprietary suppressor tRNA technology that … siccin yts